Healthcare

The declaration of new tariffs on generic drugs anticipated to start in 2028 signals a strategic push by the Trump administration to bolster U.S. drug manufacturing. The policy framework aims to reshape the pharmaceutical sector, which relies heavily on foreign suppliers, particularly in India …

Universal Health Services Inc. (NYSE: UHS) has broadened its senior secured credit framework through a new delayed‑draw term loan commitment of up to $700 million.

Jupiter Neurosciences (NASDAQ: JUNS) has entered into a license agreement with Canadian biotech PharmAla, granting Jupiter exclusive rights to develop and market the investigational psychedelic ALA‑002 in the United States.

Neuronetics, Inc. This change comes amid a period of notable growth for the company, which has seen its shares rise 30.6% year-to-date. The appointment is particularly critical for investors, as Neuronetics seeks to enhance its financial strategy amidst a recovering market and expanding operations.

Nutex Health Inc. (NASDAQ: NUTX) has achieved a significant milestone by slashing its administrative fee for the Federal Independent Dispute Resolution (IDR) process from $115 to $15, a dramatic 87% reduction. This strategic move is part of the first amendment to its Payment Dispute …

Picard Medical, Inc. (NYSE American: PMI) is set to execute a reverse stock split as part of its efforts to enhance its market position and comply with NYSE listing requirements. This significant decision comes as the company's shares have experienced a remarkable decline year-to-date. …

Polaryx Therapeutics, Inc. (NASDAQ: PLYX) is witnessing a notable leadership change as Chief Medical Officer Dr. Lisa Bollinger has resigned, effective immediately. This development comes on the heels of a recent purchase of over $360,000 worth of company stock by the CEO.